FDNA Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
38
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$27.5M
- Investors
-
2
FDNA General Information
Description
Developer of an artificial intelligence-based phenotyping technology designed to analyze relevant genomic and phenotypic information. The company's technology detects physiological patterns that reveal disease-causing genetic variations, which are analyzed and included in their comprehensive database of clinically relevant genomic and phenotypic information, enabling clinicians, labs, and researchers to address genetic disease problems in healthcare.
Contact Information
Website
www.fdna.comCorporate Office
- 309 East Paces Ferry Road
- Suite 400
- Atlanta, GA 30305
- United States
Corporate Office
- 309 East Paces Ferry Road
- Suite 400
- Atlanta, GA 30305
- United States
FDNA Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Later Stage VC (Series B) | $27.5M | Completed | Generating Revenue |
FDNA Patents
FDNA Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3635595-A1 | Systems, methods, and computer-readable media for gene and genetic variant prioritization | Pending | 08-Jun-2017 | ||
| US-10470659-B2 | Systems, methods, and computer-readable media for gene and genetic variant prioritization | Active | 08-Jun-2017 | ||
| US-20180353072-A1 | Systems, methods, and computer-readable media for gene and genetic variant prioritization | Active | 08-Jun-2017 | ||
| WO-2018227154-A1 | Systems, methods, and computer-readable media for gene and genetic variant prioritization | Inactive | 08-Jun-2017 | ||
| US-10327637-B2 | Systems, methods, and computer-readable media for patient image analysis to identify new diseases | Active | 08-Jun-2017 | A61B5/0013 |
FDNA Signals
FDNA Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Clal Biotechnology Industries | Venture Capital | Minority | ||
| Nacre Capital | Venture Capital | Minority |
FDNA FAQs
-
When was FDNA founded?
FDNA was founded in 2011.
-
Where is FDNA headquartered?
FDNA is headquartered in Atlanta, GA.
-
What is the size of FDNA?
FDNA has 38 total employees.
-
What industry is FDNA in?
FDNA’s primary industry is Decision/Risk Analysis.
-
Is FDNA a private or public company?
FDNA is a Private company.
-
What is the current valuation of FDNA?
The current valuation of FDNA is .
-
What is FDNA’s current revenue?
The current revenue for FDNA is .
-
How much funding has FDNA raised over time?
FDNA has raised $27.5M.
-
Who are FDNA’s investors?
Clal Biotechnology Industries and Nacre Capital have invested in FDNA.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process